Neura Health

Neura Health operates a virtual neurology clinic that connects patients in the United States with board-certified neurologists, neurological sub-specialists, physician assistants and nurse practitioners via video visits and in-app messaging. Conditions covered include headache and migraine, epilepsy and seizures, sleep disorders such as insomnia, sleep apnea, restless legs syndrome, parasomnias and hypersomnias including narcolepsy, chronic pain, concussion and traumatic brain injury, stroke recovery, tremor, long COVID, dementia and memory disorders, and undiagnosed neurological symptoms. The company positions its model against months-long waits for in-person neurology appointments, advertising appointments within seven days.

Beyond consultations, the platform provides personalized treatment plans that can include prescriptions delivered to patients, ordering of labs and imaging at local in-network facilities, referrals for in-person procedures such as injections or infusions with continued oversight by Neura clinicians, integrated symptom tracking with pre-visit summaries for providers, EHR integration, care navigation and concierge support, patient education, and sessions with board-certified health and wellness coaches (NBC-HWC). The company also describes AI-powered workflows intended to reduce administrative burden for providers, and states it is aggregating a real-world evidence dataset of neurology outcomes, symptoms and treatment data that has drawn interest from pharmaceutical manufacturers.

Commercial offerings are structured as a membership plan bundling ongoing care, unlimited chat, support and two monthly coaching visits, and a per-visit option (Neura Flex) for one-time consultations or second opinions. The clinical team includes neurologists and specialists drawn from institutions such as New York University, Montefiore Medical Center, UC Irvine and the Ray Dolby Brain Health Center.

Founding story

Co-founder and CEO Elizabeth Burstein previously led product development at LinkedIn, Maven Clinic and Zocdoc. In March 2020 she developed a complicated nerve entrapment condition and, despite seven radiology exams, three rounds of physical therapy and ten nerve blocks and epidural steroid injections, found no effective relief. Her experience with fragmented care, difficulty accessing specialists, and the inability to find a clinician willing to engage with the symptom data she tracked herself motivated the creation of Neura Health.

Business model

Neura Health charges for clinical care delivered virtually. It is in network with more than 40 health plans — including Aetna, Blue Shield of California, Cigna, Sana, Anthem Blue Cross, TriWest and Medicare — so patients can pay a copay; self-pay patients pay list prices ($249 for an initial 45-minute visit, $154 for a 20-minute follow-up) and can receive a superbill for potential out-of-network reimbursement. A membership plan bundles ongoing management, unlimited chat, dedicated support and two monthly coaching visits (coaching described as valued at $98/month), while Neura Flex serves one-time or occasional visits. Contracts with health systems and life-sciences referral partners are described as primarily fee-for-service, with performance guarantees or value-based arrangements offered to some payers.

Revenue comes from per-visit fees reimbursed by health plans or paid directly by patients, subscription membership fees for ongoing care and coaching, and fee-for-service agreements with health system and life sciences partners; some payer contracts include performance guarantees or value-based terms.

Traction

As of the September 2025 Series A announcement, Neura Health had served more than 43,000 patients nationwide and was in network with more than 40 health plans. Published outcomes cite a 73% reduction in ER and urgent care visits and a 66% increase in patients' global impression of improvement; the company's site reports median three-month changes of a 45% increase in global impression of improvement, a 13% reduction in PHQ-9 depression levels, and 95% of patients rating Neura 5 out of 5, with a separate landing page citing 75% reduction in symptom frequency and 67% reduction in symptom severity. Clinical results were published in Headache (2022), the Journal of Clinical Medicine (2023) and Current Neurology and Neuroscience Reports (2025). A third-party review site lists a 4.9 rating from 34 reviews with 97% of reviewers recommending the service.

Latest developments

In September 2025 Neura Health announced an $11.4 million Series A led by the American Heart Association's Go Red for Women Venture Fund — the fund's first investment — with participation from Norwest Venture Partners, Koch Disruptive Technologies, Esplanade Ventures, Pear VC, Correlation Ventures and E12 Ventures. The company said proceeds would fund national expansion, growth with payers and health systems, and entry into additional condition areas, following a recent expansion into memory care for dementia patients.